Integrative machine learning approach to identify the bio-markers of breast cancer treatment outcome

Integrative machine learning approach to identify the bio-markers of breast cancer treatment outcome

by Pham Cong Hui

Formal & Physical Sciences Biology PSALife sciences: general issuesPSAXComputational biology
🎙 Pham Cong Hui 👥 2K 📅 June 20, 2018 ⏱ 15 min 👁 993 📄 original study 🧭 2026-08-18
Available in: English (current) Français

Keywords

SVMfeature selectiongene expressionMETABRICtreatment outcome

Summary

The presentation by Pham Cong Hui from the University of Windsor describes an integrative machine learning approach to identify biomarker genes for predicting breast cancer survivability after different treatments. The study uses METABRIC 2016 data with gene expression profiles of about 25,000 genes from nearly 2,000 patients. A support vector machine (SVM) with linear kernel is used in a recursive feature elimination manner to select a subset of genes for each treatment combination. The classification task is a three-class problem: disease-free, died before five years, or died after five years. For each treatment, about 190 genes are selected, achieving high accuracy, with the highest around 98% for patients treated with chemotherapy and radiation therapy. The selected genes are analyzed for biological relevance, with many being cancer-related and involved in relevant pathways. The results suggest these genes could be potential biomarkers, but further biological validation is needed. Future work includes integrating other data types and comparing with other methods.

158 words

Critical Evaluation

Value of the Information & Strength of the Argument

The value of the information lies in the novel three-class classification approach and the identification of gene sets with high predictive accuracy. The argumentation is based on a clear methodology and results, but the presentation lacks detailed statistical validation and comparison with existing methods. The biological relevance analysis adds value, but the evidence is not conclusive.

Scientific Rigor, Source Quality, Title Accuracy

The study uses a well-known public dataset (METABRIC) and follows a standard machine learning pipeline. The sources cited are limited to the dataset and general pathway databases, but no specific references are provided in the video. The title accurately reflects the content. The presentation is somewhat informal, and the transcription contains errors, but the scientific content is coherent.

129 words

Title / Content Match

The title accurately reflects the content, which focuses on using machine learning to identify biomarkers for breast cancer treatment outcomes.

Quality & Reliability

7/10

The study presents a clear methodology and results, but lacks external validation and detailed statistical analysis. The presentation is somewhat informal and the transcription contains errors, but the core scientific content is coherent.

Key Moments

Markers derived by PSI from the transcript: the creator did not define chapters.

Cited Sources

  • METABRIC 2016 dataset — Used as the primary data source for gene expression and clinical data.

Concurring Sources

  • METABRIC dataset — The dataset is widely used in breast cancer research and supports the study's findings.

Contribution & Novelties

The study introduces a three-class classification approach for breast cancer survivability, which is more nuanced than typical binary classification. It also identifies gene sets for different treatment combinations, providing potential biomarkers. The use of SVM with recursive feature elimination is standard but applied to a new problem.

Pour aller plus loin :

83 words

Radar Profile

The radar profile shows balanced scores across information quantity, quality, and technical level, with slightly lower reliability, indicating a solid but not fully validated study.

Reliability 6/10